论文部分内容阅读
目的分析缩宫素及米索前列醇在预防产后出血中的临床应用效果。方法 120例分娩产妇,根据数字平行法分为A组(60例)和B组(60例),A组在予以缩宫素同时,给予米索前列醇;B组单独使用缩宫素,分析两组患者的产后出血情况。结果 A组产后出血率、第三产程时间、2 h产后出血量均少于B组,差异有统计学意义(P<0.05),两组患者出现头晕、恶心轻微症状,可耐受。结论缩宫素及米索前列醇在产妇分娩后中的应用,具有显著的产后出血预防作用,安全性高,值得作为预防产妇产后出血的理想药物。
Objective To analyze the clinical effect of oxytocin and misoprostol in preventing postpartum hemorrhage. Methods A total of 120 maternal births were divided into group A (60 cases) and group B (60 cases) according to digital parallel method. Group A received oxytocin and oxytocin while group B used oxytocin alone. Postpartum hemorrhage in both groups. Results The rate of postpartum hemorrhage, the third stage of labor and the amount of postpartum hemorrhage after 2 hours in group A were all less than those in group B (P <0.05). Both groups showed mild symptoms of dizziness and nausea and were tolerable. Conclusion The application of oxytocin and misoprostol in postpartum delivery has significant preventive effect on postpartum hemorrhage and is safe and worthwhile as an ideal drug for preventing postpartum hemorrhage.